Elena Castro

8.7k total citations · 2 hit papers
116 papers, 2.8k citations indexed

About

Elena Castro is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Elena Castro has authored 116 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 59 papers in Oncology and 33 papers in Molecular Biology. Recurrent topics in Elena Castro's work include Prostate Cancer Treatment and Research (81 papers), PARP inhibition in cancer therapy (49 papers) and DNA Repair Mechanisms (25 papers). Elena Castro is often cited by papers focused on Prostate Cancer Treatment and Research (81 papers), PARP inhibition in cancer therapy (49 papers) and DNA Repair Mechanisms (25 papers). Elena Castro collaborates with scholars based in Spain, United Kingdom and United States. Elena Castro's co-authors include Rosalind A. Eeles, Karim Fizazi, David Olmos, Chris Parker, Axel Heidenreich, Bertrand Tombal, Silke Gillessen, Giuseppe Procopio, Piet Ost and Chee Goh and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elena Castro

104 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2020 577 citations Elena Castro, Karim Fizazi et al. Annals of Oncology profile →
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial

2021 183 citations Johann S. de Bono, Niven Mehra et al. profile →

Peers

Countries citing papers authored by Elena Castro

Since Specialization

Citations

This map shows the geographic impact of Elena Castro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Castro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Castro more than expected).

Fields of papers citing papers by Elena Castro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Castro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Castro. The network helps show where Elena Castro may publish in the future.

Co-authorship network of co-authors of Elena Castro

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Castro. A scholar is included among the top collaborators of Elena Castro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Castro. Elena Castro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MEVROMETOSTAT (PF-06821497) IN COMBINATION WITH ENZALUTAMIDE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE: THE PHASE 3, RANDOMIZED MEVPRO-1 STUDY 2025 ·Urologic Oncology Seminars and Original Investigations ·Neeraj Agarwal, Michael T. Schweizer, Elena Castro, Arun Azad, Daniel J. George, Jayeta Chakrabarti, Sujata Narayanan, Yiyun Tang, Karim Fizazi	1
2	BCG Immunotherapy in Equine Sarcoid Treatment: Mechanisms, Clinical Efficacy, and Challenges in Veterinary Oncology 2025 ·Viruses ·(unknown), Elena Castro, (unknown), (unknown), (unknown), Felipe Masiero Salvarani	0
3	Prostate cancer germline variants with therapeutic implications 2025 ·Trends in Molecular Medicine ·(unknown), Elena Castro, Nima Sharifi	0
4	Patient-reported Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1/2 Gene Alterations: Final Analysis from the Randomized Phase 3 MAGNITUDE Trial 2024 ·European Urology ·Dana E. Rathkopf, Guilhem Roubaud, Kim N., Eleni Efstathiou, Gerhardt Attard, David Olmos, Eric J. Small, Marniza Saad, Elena Castro, Won Kim, Daphne Wu, (unknown), Shiva Dibaj, Jenny Zhang, Peter Francis, Matthew R. Smith	5
5	Immunome profiling in prostate cancer: a guide for clinicians 2024 ·Frontiers in Immunology ·Luís Manso, Arántzazu Alfranca, (unknown), María Dolores Martínez Ruiz, (unknown), (unknown), (unknown), A. Zapatero, (unknown), (unknown), (unknown), Maurício Maza, (unknown), Elena Castro, David Olmos, Rámón Colomer, Nuria Romero-Laorden	2
6	LBA85 Niraparib (NIRA) with abiraterone acetate plus prednisone (AAP) as first-line (1L) therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations: Three-year update and final analysis (FA) of MAGNITUDE 2023 ·Annals of Oncology ·(unknown), Elena Castro, Gerhardt Attard, Matthew R. Smith, Shahneen Sandhu, Eleni Efstathiou, Guilhem Roubaud, Eric J. Small, (unknown), Dana E. Rathkopf, Marniza Saad, Howard Gurney, Wonho Jung, Gary Mason, Shiva Dibaj, Daphne Wu, B. Diorio, Angela Lopez‐Gitlitz, (unknown), David Olmos	6
7	1815P Emergent circulating tumor DNA (ctDNA) variants and ctDNA burden dynamics with potential associations with talazoparib antitumor activity in TALAPRO-1 2023 ·Annals of Oncology ·Elena Castro, Douglas Laird, (unknown), Shuang G. Zhao, Inge M. van Oort, Donatello Gasparro, Fabio Calabrò, Sandro Pignata, Lajos Géczi, Philippe Barthélémy, Deepak Kilari, (unknown), Hsiang‐Cheng Chen, Cynthia G. Healy, Jijumon Chelliserry, Giorgio V. Scagliotti, Johann S. de Bono, (unknown), Karim Fizazi	2
8	Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate Cancer 2023 ·Clinical Genitourinary Cancer ·Yanin Chávarri-Guerra, María T. Bourlon, (unknown), (unknown), (unknown), (unknown), (unknown), Elena Castro, Danielle Castillo, Josef Herzog, Jeffrey N. Weitzel	3
9	1806P Efficacy of niraparib and abiraterone acetate plus prednisone (NIRA+AAP) in homologous recombination repair gene-altered (HRR+) metastatic castration-resistant prostate cancer (mCRPC) by tissue and/or plasma assays in the MAGNITUDE trial 2023 ·Annals of Oncology ·G. Attard, Shahneen Sandhu, Dana E. Rathkopf, Elena Castro, Marniza Saad, Mitchell R. Smith, Eric J. Small, David Olmos, (unknown), Guilhem Roubaud, Bogdan Żurawski, Eleni Efstathiou, Daphne Wu, B. Diorio, Karen Urtishak, Umesh Singh, Yan Xu, Angela Lopez‐Gitlitz, (unknown), K.N. Chi	2
10	Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses 2022 ·The Oncologist ·Niven Mehra, Karim Fizazi, Johann S. de Bono, Philippe Barthélémy, Tanya B. Dorff, (unknown), Jean‐Pascal Machiels, Davide Bimbatti, Deepak Kilari, Herlinde Dumez, Consuelo Buttigliero, Inge M. van Oort, Elena Castro, Hsiang-Chun Chen, Nicola Di Santo, (unknown), Cynthia G. Healy, Giorgio V. Scagliotti	11
11	SEOM clinical guidelines for the treatment of advanced prostate cancer (2020) 2021 ·Clinical & Translational Oncology ·Aranzazu González del Alba, María José Méndez-Vidal, (unknown), Elena Castro, José A. Martínez-Climent, Enrique Gallardo, Enrique González‐Billalabeitia, David Lorente, Pablo Maroto, (unknown)	21
12	Optimal Sequencing and Predictive Biomarkers in Patients with Advanced Prostate Cancer 2021 ·Cancers ·Carlo Cattrini, (unknown), Alessia Mennitto, Melissa Bersanelli, Elena Castro, David Olmos, David Lorente, Alessandra Gennari	28
13	DNA Damage Repair Gene Mutation Testing and Genetic Counseling in Men With/without Prostate Cancer: a Systematic Review 2020 ·Future Oncology ·Nigel Armstrong, Ruben G.W. Quek, Steve Ryder, Janine Ross, (unknown), Carol Forbes, Kathleen M. Fox, Elena Castro	2
14	High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriers 2015 ·Annals of Oncology ·Elena Castro, Sarah Jugurnauth-Little, (unknown), Fátima Al‐Shahrour, Elena Piñeiro-Yáñez, (unknown), Daniel Leongamornlert, Tokhir Dadaev, Koveela Govindasami, Michelle Guy, Rosalind A. Eeles, Zsofia Kote‐Jarai	25
15	State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer 2014 ·Elena Castro, Nuria Romero-Laorden, David Olmos	2
16	Diffusion-weighted MRI for detecting prostate tumour in men at increased genetic risk 2014 ·European Journal of Radiology Open ·Nandita M. deSouza, Veronica A. Morgan, Elizabeth Bancroft, S.A. Sohaib, Sharon Giles, Zsofia Kote‐Jarai, Elena Castro, Steven Hazell, (unknown), Rosalind A. Eeles	6
17	The genetic epidemiology of prostate cancer and its clinical implications 2013 ·Nature Reviews Urology ·Rosalind A. Eeles, Chee Goh, Elena Castro, Elizabeth Bancroft, Michelle Guy, Ali Amin Al Olama, Douglas F. Easton, Zsofia Kote‐Jarai	175
18	The role of BRCA1 and BRCA2 in prostate cancer 2012 ·Asian Journal of Andrology ·Elena Castro, Rosalind A. Eeles	102
19	BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients 2011 ·British Journal of Cancer ·(unknown), Zsofia Kote‐Jarai, Daniel Leongamornlert, Edward J. Saunders, Malgorzata Tymrakiewicz, Elena Castro, Nadiya Mahmud, Michelle Guy, Sandra E. Edwards, L O'Brien, Elinor J. Sawyer, Amanda L. Hall, Rosemary Wilkinson, Tokhir Dadaev, Chee Goh, Douglas F. Easton, David E. Goldgar, Rosalind A. Eeles	256
20	Modulation of a Delayed-Rectifier K⁺ Current by Angiotensin II in Rat Sympathetic Neurons 2007 ·Journal of Neurophysiology ·(unknown), (unknown), Elena Castro, Humberto Cruzblanca	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact